Latren injection solution 200ml 0,05% Pentoxifylline Латрен

Latren Indications

- Arteriosclerotic encephalopathy; ischemic cerebral stroke;

- encephalopathy;

- peripheral circulatory disorders caused by atherosclerosis, diabetes (including diabetic angiopathy), inflammation;

- trophic disorders in the tissues associated with damage to veins or the microcirculation disturbance (post-thrombotic syndrome, trophic ulcers, gangrene, frostbite);

- occlusive disease; angioneyropatiya (Raynaud's disease);

- eye blood circulation infringement (acute, subacute, chronic insufficiency of blood circulation in the retina and choroid);

- dysfunction of the inner ear vascular genesis, which is accompanied by hearing loss.

Dosage & Administration

Injections are the most effective way of parenteral administration, are better tolerated. Dosage regimen determined by a physician and depends on the severity of circulatory disorders, body weight and tolerance to treatments. Infusion may be carried out only if pp transparent.

Adults are recommended such treatment regimes:

1. / IV infusion of 100-600 mg of pentoxifylline 1-2 times a day. Duration is 60-360 minutes, that is, the introduction of 100 mg of pentoxifylline should last at least 60 minutes;

2. In severe patient's condition (particularly at a constant pain, trophic ulcers or gangrene) Infusion may pentoxifylline holding for 24 hours. At this dose regimen of determining the rate of 0.6 mg / kg / h. The calculated daily dose for a patient weighing 70 kg is 1000 mg for a patient weighing 80 kg - 1150 mg. Regardless of patient body weight maximum daily dose is 1200 mg. The volume of the infusion of p-ra is calculated individually taking into account comorbidities, patient's condition and averages 1-1.5 liters / day.

The duration of parenteral treatment is determined by the doctor who is treating.

Contradictions

Hypersensitivity to the drug and xanthine derivatives. Acute myocardial infarction.

Porphyry. Massive bleeding at the time of appointment of the drug or diagnosed on the eve of his appointment.

Hemorrhagic diathesis, extensive hemorrhages in the retina of the eye (you should immediately stop using the product). Arrhythmia, severe atherosclerosis of the coronary or cerebral vessels, uncontrolled hypotension.

Liver and / or kidney failure. Gastric ulcer and / or intestinal ulcers. Bleeding in the brain (risk of increased bleeding).